Korro Bio, Inc. (KRRO)
NASDAQ: KRRO · Real-Time Price · USD
12.30
+1.12 (10.02%)
At close: Mar 9, 2026, 4:00 PM EDT
12.06
-0.24 (-1.93%)
After-hours: Mar 9, 2026, 7:54 PM EDT
Korro Bio Market Cap
Korro Bio has a market cap or net worth of $115.83 million as of March 9, 2026. Its market cap has decreased by -56.84% in one year.
Market Cap
115.83M
Enterprise Value
58.01M
1-Year Change
-56.84%
Ranking
Category
Stock Price
$12.30
Market Cap Chart
Since November 6, 2023, Korro Bio's market cap has decreased from $123.80M to $115.83M, a decrease of -6.43%. That is a compound annual growth rate of -2.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 105.29M | 39.58% |
| Dec 31, 2025 | 75.43M | -78.85% |
| Dec 31, 2024 | 356.65M | -6.96% |
| Dec 29, 2023 | 383.31M | 209.63% |
| Nov 6, 2023 | 123.80M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Inovio Pharmaceuticals | 120.92M |
| Black Diamond Therapeutics | 120.79M |
| Precision BioSciences | 120.36M |
| Gain Therapeutics | 116.16M |
| Oncolytics Biotech | 112.99M |
| Codexis | 112.91M |
| Coya Therapeutics | 111.37M |
| Agenus | 107.81M |